On Friday, Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) opened lower -6.70% from the last session, before settling in for the closing price of $3.73. Price fluctuations for IRWD have ranged from $0.53 to $5.13 over the past 52 weeks.
During the last 5-year period, the sales drop of Healthcare Sector giant was -47.49%. Company’s average yearly earnings per share was noted 1448.53% at the time writing. With a float of $156.69 million, this company’s outstanding shares have now reached $162.68 million.
Ironwood Pharmaceuticals Inc (IRWD) Insider Activity
A key investor’s attitude towards the stock of the Drug Manufacturers – Specialty & Generic industry is another important factor to consider. The insider ownership of Ironwood Pharmaceuticals Inc is 3.68%, while institutional ownership is 91.66%. The most recent insider transaction that took place on Nov 17 ’25, was worth 19,973. In this transaction Chief Commercial Officer of this company sold 6,016 shares at a rate of $3.32, taking the stock ownership to the 235,264 shares. Before that another transaction happened on Nov 17 ’25, when Company’s Officer proposed sale 6,324 for $3.37, making the entire transaction worth $21,312.
Ironwood Pharmaceuticals Inc (IRWD) Earnings and Forecasts
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted 0.02 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at 0.08) by -0.06. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.02 per share during the current fiscal year.
Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) Trading Performance Indicators
Check out the current performance indicators for Ironwood Pharmaceuticals Inc (IRWD). In the past quarter, the stock posted a quick ratio of 1.13. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.67. Likewise, its price to free cash flow for the trailing twelve months is 8.37.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.15, a number that is poised to hit 0.02 in the next quarter and is forecasted to reach 0.45 in one year’s time.
Technical Analysis of Ironwood Pharmaceuticals Inc (IRWD)
Looking closely at Ironwood Pharmaceuticals Inc (NASDAQ: IRWD), its last 5-days average volume was 1.79 million, which is a drop from its year-to-date volume of 2.57 million. As of the previous 9 days, the stock’s Stochastic %D was 67.42%.
During the past 100 days, Ironwood Pharmaceuticals Inc’s (IRWD) raw stochastic average was set at 86.00%, which indicates a significant increase from 53.61% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.34 in the past 14 days, which was higher than the 0.17 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.25, while its 200-day Moving Average is $1.32. However, in the short run, Ironwood Pharmaceuticals Inc’s stock first resistance to watch stands at $3.73. Second resistance stands at $3.99. The third major resistance level sits at $4.17. If the price goes on to break the first support level at $3.29, it is likely to go to the next support level at $3.11. Should the price break the second support level, the third support level stands at $2.85.
Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) Key Stats
There are currently 162,679K shares outstanding in the company with a market cap of 566.12 million. Presently, the company’s annual sales total 351,410 K according to its annual income of 880 K. Last quarter, the company’s sales amounted to 122,060 K and its income totaled 40,080 K.
